PNS-24931-86241
2 vaccinations
4 coded responses
16 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 100 / NY
- Registered
- 2022-10-26
- Relationship
- Child or adolescent in my care
- Guardian
- 34Z-38493-37155
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-25
Dose 1 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-26
Registered in v-safe
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-10-31
- 2022-11-04
-
2022-11-08
Survey response — day 14, dose 1, under 3MedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2024-11 · check-in free text available
-
2022-11-15
Survey response — day 21, dose 1, under 3MedDRA: Cough, Rhinorrhoea — Feeling: FairFree text: Cough, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-11-16
Dose 2 — Pfizer-BioNTech
- 2022-11-16
-
2022-11-17
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Site: Pain · DiarrheaUnder 3 check-in
- 2022-11-19
- 2022-11-23
- 2022-12-07
- 2022-12-14
-
2022-12-22
Survey response — day 35, dose 2, under 3MedDRA: Cough, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever and coughMedDRA releases: 2024-11 · check-in free text available
-
2023-02-17
Survey response — 3 months, dose 2, under 3MedDRA: Ear infection, Unevaluable event, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-17
Report sent to call center — 3 months, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-02-20
- 2023-05-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-25 | Pfizer-BioNTech | Flu |
| 2 | 2022-11-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Cough
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Cough, runny nose
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Fever and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release